New HIV vaccine shows unprecedented success in preclinical study
Highlights:
Scientists at La Jolla Institute for Immunology, Scripps Research have developed an HIV vaccine that trains immune cells to see past HIV’s defenses.
This HIV vaccine works by prompting the body’s immune system to make substantial numbers of rarely seen “broadly neutralizing” antibodies.
In this new study, this vaccine resulted in the best HIV-fighting antibody response ever seen in primates. Human trials have now started.
LJI Professor and Chief Scientific Officer Shane Crotty, Ph.D....
Read more at lji.org